Drugmakers curb Swiss reimbursement applications over US pricing concerns

Drugmakers are holding back applications for health insurance coverage in Switzerland over concerns that lower prices there could affect their U.S. ​business under drug-pricing policies introduced by the Trump administration, a study ‌showed on Thursday.